Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, et al. Indications for autologous and allogeneic hematopoietic cell transplantation: American Society for Blood and Marrow Transplantation guidelines. Bio blood bone marrow transplant. 2015;21:1863–9.
Simonin M, Dalissier A, Labopin M, Willasch A, Zecca M, Mouhab A, et al. Non-relapse mortality is more chronic after peripheral blood stem cells compared to bone marrow in hematopoietic transplantation for childhood acute lymphoblastic leukemia, a retrospective study on behalf of the EBMT Pediatric Disease Working Group. Bone marrow transplantation. 2017;52:1071–3.
Bacigalupo A, Socié G, Schrezenmeier H, Tichelli A, Locasciulli A, Fuehrer M, et al. Bone marrow and peripheral blood as stem cell sources for sibling transplantation in acquired aplastic anemia: Survival benefits of bone marrow in all age groups. Haematologica. 2012;97:1142–8.
Walker I, Panzarella T, Cuban S, Couture F, Devins G, Elemarie M, et al. Pretreatment with antithymocyte globulin versus no antithymocyte globulin in patients with hematological malignancies undergoing hematopoietic cell transplantation from unrelated donors: a randomized, controlled, open-label, phase 3, multicenter trial. Lancet Oncor. 2016;17:164-73.
Gorin NC, Labopin M, Rocha V, Arcese W, Beksac M, Gluckman E, et al. Bone marrow and peripheral blood in gene-identical allogeneic stem cell transplantation in acute myeloid leukemia: Effects of dose and stem cell source indicate favorable outcomes when bone marrow is abundant. blood. 2003;102:3043–51.
Sierra J, Storer B, Hansen JA, Bjelke JW, Martin PJ, Petersdorf EW, et al. Transplantation of bone marrow cells from unrelated donors for the treatment of high-risk acute leukemia: Effects of leukemic burden, donor HLA match, and bone marrow cell dose. blood. 1997;89:4226–35.
Remberger M, Ringden O, Mattsson J. Bone marrow aspiration techniques have deteriorated in recent years. Bone marrow transplantation. 2015;50:1007-9.
Hequet O. Harvesting hematopoietic stem and progenitor cells: technological advances and clinical utility. J Blood Med. 2015;6:55.
Dubois V, Amocrane K, Bigine Y, Bruno B, Chevalier P, Delbos F, et al. Greff des cells sous hematopo étics haploidentifique avec cyclophosphamide en postgrefe: Comment choisir le meilleur donneur en 2019? Recommandations de la Société francophone de greffe de mÅ“lle et de thérapie cellulaire (SFGM-TC). Bull Cancer. 2020;107:S72-84.
Buckner C, Clift R, Saunders J, Stewart P, Bensinger W, Donney K, et al. Bone marrow harvest from conventional donors. blood. 1984;64:630 – 4.
Batinić D, Marsić M, Pavletić Z, Bogdanić V, Uzarević B, Nemet D, et al. Relationship between different volumes of bone marrow aspirate and its cellular composition. Bone marrow transplantation. 1990;6:103-7.
